CHAPEL HILL, NC, USA – July 11, 2018 – The World Thrombosis Day campaign today announced that LEO Pharma A/S has joined the campaign as a Global Patron in support of its global awareness initiative to reduce death and disability caused by thrombosis, also known as blood clots. Observed on 13 October, World Thrombosis Day, led by the International Society on Thrombosis and Haemostasis (ISTH), mobilizes 1,500 partner organizations to hold more than 9,000 awareness events worldwide each year. Last year alone, the campaign reached an estimated 2.7 billion people in an effort to shine a spotlight on the burden of this condition.
LEO Pharma A/S is a leading global pharmaceutical company dedicated to helping patients worldwide who suffer from potentially life-threatening and disabling diseases, including venous thromboembolism (VTE). Blood clots are one of the leading causes of death in patients with cancer. Approximately one in ten patients with cancer dies from a blood clot related event 1, 2 showcasing the importance for LEO Pharma A/S to take part in this worldwide initiative.
“LEO Pharma A/S is proud to support the important work of the World Thrombosis Day campaign,” said Xavier Bertin, Vice President, Global Business Unit Thrombosis of LEO Pharma A/S. “We have provided products for thrombosis patients for more than 50 years with a specific focus on cancer associated thrombosis the past eight years. This new collaboration underscores our passion for helping patients.”
One in four deaths worldwide is related to thrombosis, highlighting the urgent need for awareness and patient empowerment to ask for a risk assessment 3, 4. With the tagline, Know Thrombosis, the campaign encourages the general public, healthcare professionals, and key decision makers to know and take action on the risk factors, signs, and symptoms of the condition.
“As we recognize the fifth anniversary of World Thrombosis Day, we are delighted to welcome LEO Pharma A/S to the campaign as a Global Patron,” said Gary Raskob, PhD, Chairman of the World Thrombosis Day Steering Committee. “LEO Pharma A/S’ partnership is critical to our efforts in raising awareness of VTE and its prevention and treatment, which ultimately saves lives.”
- ENDS -
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 5,200 people worldwide.
About World Thrombosis Day
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. WTD’s mission supports the World Health Assembly's global target (pdf) of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. Visit www.worldthrombosisday.org for more information and to get involved.
About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with more than 5,000 clinicians, researchers and educators working together to improve the lives of patients in more than 98 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org.
- Gussoni G, Frasson S, La Regina M et al. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res 2013; 131:24-30.
- Khorana AA, Francis CW, Culakova E et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007;5: 632-634.
- Journal of Thrombosis and Haemostasis, “Thrombosis: A Major Contributor to the Global Disease Burden.” www.worldthrombosisday.org/issue/global-burden-vte/
- World Health Organization (WHO), “65th World Health Assembly Closes with New Global Health Measures,” (2012). www.who.int/mediacentre/news/releases/2012/wha65_closes_20120526/en/